Moonlake Immunotherapeutics Ag
Clinical trials sponsored by Moonlake Immunotherapeutics Ag, explained in plain language.
-
New arthritis drug seeks Long-Term safety green light
Disease control ENROLLING_BY_INVITATIONThis study aims to check the long-term safety and effectiveness of an experimental drug called sonelokimab for people with psoriatic arthritis. It is an extension study for about 1,560 participants who have already completed a previous related trial. The main goal is to see how w…
Phase: PHASE3 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New arthritis drug shows promise in major trial
Disease control OngoingThis study is testing whether a new injectable medication called sonelokimab can help control psoriatic arthritis symptoms in adults who haven't tried similar biologic treatments before. Researchers are comparing two dosing schedules of sonelokimab against placebo injections in 9…
Phase: PHASE3 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New Long-Term skin treatment study seeks to control painful condition
Disease control ENROLLING_BY_INVITATIONThis study aims to learn about the long-term safety and effectiveness of an investigational drug called sonelokimab for people with moderate to severe hidradenitis suppurativa (HS), a painful skin condition. It is open to about 835 people who have already taken part in a previous…
Phase: PHASE3 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC